All In Biotech

Drug Trial Radar · NCT00081380

Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Multicenter, Randomized, Parallel-Group, Double-Blind, Phase 3 Comparison of the Efficacy & Safety of Quetiapine Fumarate to Placebo as Adjunct to Mood Stabilizers (Lithium or Divalproex) in the Maintenance Treatment of Bipolar I Disorder in Adult Patients (Abbreviated)

Last checked: Nov 19, 2026Latest source record: Dec 22, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 710 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

710

Actual

Start

Mar 2004

Primary completion

Not stated

Study completion Sep 2006

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Apr 19, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether quetiapine when used as adjunct to lithium or divalproex is safe and effective in the maintenance treatment of adult patients with Bipolar I Disorder. The study consists of enrollment and 2 phases, the Open-label treatment Phase and the Randomized treatment Phase. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Conditions

  • Bipolar Disorder

Interventions

  • Seroquel®, quetiapine fumarate (atypical antipsychotic)Drug

  • lithium (mood stabilizer)Drug

  • divalproex (mood stabilizer)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluate the efficacy of quetiapine versus placebo when used as adjunct therapy to mood stabilizer in increasing time to recurrence of a mood event.

Locations

94 sites in 2 countries. Site status is shown where the registry gives one.

  • Research Site

    Birmingham, Alabama

  • Research Site

    Scottsdale, Arizona

  • Research Site

    Little Rock, Arkansas

  • Research Site

    Anaheim, California

  • Research Site

    Cerritos, California

  • Research Site

    Chula Vista, California

  • Research Site

    Culver City, California

  • Research Site

    Garden Grove, California

  • Research Site

    La Mesa, California

  • Research Site

    Oceanside, California

  • Research Site

    Orange, California

  • Research Site

    Pico Rivera, California

  • Research Site

    Riverside, California

  • Research Site

    Rosemead, California

  • Research Site

    San Diego, California

  • Research Site

    San Francisco, California

  • Research Site

    Santa Ana, California

  • Research Site

    Farmington, Connecticut

  • Research Site

    New Britain, Connecticut

  • Research Site

    Jacksonville, Florida

  • Research Site

    Miami, Florida

  • Research Site

    Orlando, Florida

  • Research Site

    West Palm Beach, Florida

  • Research Site

    Winter Park, Florida

  • Research Site

    Atlanta, Georgia

  • Research Site

    Decatur, Georgia

  • Research Site

    Marietta, Georgia

  • Research Site

    Smyrna, Georgia

  • Research Site

    Honolulu, Hawaii

  • Research Site

    Chicago, Illinois

  • Research Site

    Hoffman Estates, Illinois

  • Research Site

    Joliet, Illinois

  • Research Site

    Evansville, Indiana

  • Research Site

    Greenwood, Indiana

  • Research Site

    Indianapolis, Indiana

  • Research Site

    Wichita, Kansas

  • Research Site

    Florence, Kentucky

  • Research Site

    Lake Charles, Louisiana

  • Research Site

    New Orleans, Louisiana

  • Research Site

    Shreveport, Louisiana

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.